Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets closed
S&P Futures
5,207.50
-7.25
(-0.14%)
Dow Futures
39,199.00
-24.00
(-0.06%)
Nasdaq Futures
18,184.25
-47.25
(-0.26%)
Russell 2000 Futures
2,047.60
-2.20
(-0.11%)
Crude Oil
82.60
-0.12
(-0.15%)
Gold
2,164.50
+0.20
(+0.01%)
United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
233.97
-1.81
(-0.77%)
At close: 04:00PM EDT
233.97
0.00
(0.00%)
After hours:
04:28PM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,327,500
2,327,500
1,936,300
1,685,500
1,483,300
Cost of Revenue
257,500
257,500
151,600
122,500
108,100
Gross Profit
2,070,000
2,070,000
1,784,700
1,563,000
1,375,200
Operating Expense
885,100
885,100
805,000
1,007,100
781,600
Operating Income
1,184,900
1,184,900
979,700
555,900
593,600
Net Non Operating Interest Income Expense
103,400
103,400
12,800
-1,900
5,100
Other Income Expense
-14,000
-14,000
-41,900
39,900
40,200
Pretax Income
1,274,300
1,274,300
950,600
593,900
638,900
Tax Provision
289,500
289,500
223,300
118,100
124,100
Net Income Common Stockholders
984,800
984,800
727,300
475,800
514,800
Diluted NI Available to Com Stockholders
984,800
984,800
727,300
475,800
514,800
Basic EPS
19.28
21.04
15.98
10.60
11.65
Diluted EPS
18.13
19.81
15.00
10.06
11.54
Basic Average Shares
46,550
46,800
45,500
44,900
44,200
Diluted Average Shares
49,550
49,700
48,500
47,300
44,600
Total Operating Income as Reported
1,184,900
1,184,900
979,700
555,900
593,600
Total Expenses
1,142,600
1,142,600
956,600
1,129,600
889,700
Net Income from Continuing & Discontinued Operation
984,800
984,800
727,300
475,800
514,800
Normalized Income
984,800
984,800
728,609
477,640
522,171
Interest Income
162,700
162,700
45,200
16,700
28,600
Interest Expense
59,300
59,300
32,400
18,600
23,500
Net Interest Income
103,400
103,400
12,800
-1,900
5,100
EBIT
1,333,600
1,333,600
983,000
612,500
662,400
EBITDA
1,386,800
1,386,800
1,034,300
662,400
712,300
Reconciled Cost of Revenue
257,500
257,500
151,600
122,500
108,100
Reconciled Depreciation
53,200
53,200
51,300
49,900
49,900
Net Income from Continuing Operation Net Minority Interest
984,800
984,800
727,300
475,800
514,800
Total Unusual Items Excluding Goodwill
0
0
-1,700
-2,300
-9,100
Total Unusual Items
0
0
-1,700
-2,300
-9,100
Normalized EBITDA
1,386,800
1,386,800
1,036,000
664,700
721,400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-391
-460
-1,729
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.